DYLAN TOYNE: Open Payments
NPI 1285295188 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 10 payments from 9 companies in 2025. Trend: 2023 $686 · 2024 $964 · 2025 $1,284
Food & beverage: $1,284
| Company | Payments | Amount |
|---|---|---|
| Sonex Health, Inc. | 1 | $251 |
| AstraZeneca Pharmaceuticals LP | 2 | $181 |
| Dexcom, Inc. | 1 | $153 |
| Tandem Diabetes Care, Inc. | 1 | $143 |
| ABBVIE INC. | 1 | $126 |
| GENZYME CORPORATION | 1 | $120 |
| CSL Behring | 1 | $120 |
| Amgen Inc. | 1 | $98 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $93 |
Products named: SX-ONE MICROKNIFE, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, AVYCAZ, FABRAZYME, Kcentra, REPATHA, BREZTRI.
Industry payments across MO — which companies pay providers there.
